Abstract:The master neuronal transcription factor NeuroD1 can directly reprogram astrocytes into induced neurons (iNeurons) after stroke. Using viral vectors to drive ectopic ND1 expression in gliotic astrocytes after brain injury presents an autologous form of cell therapy for neurodegenerative disease. Cultured astrocytes transfected with ND1 exhibited reduced proliferation and adopted neuronal morphology within 2–3 weeks later, expressed neuronal/synaptic markers, and extended processes. Whole-cell recordings detected the firing of evoked action potentials in converted iNeurons. Focal ischemic stroke was induced in adult GFAP-Cre-Rosa-YFP mice that then received ND1 lentivirus injections into the peri-infarct region 7 days after stroke. Reprogrammed cells did not express stemness genes, while 2–6 weeks later converted cells were co-labeled with YFP (constitutively activated in astrocytes), mCherry (ND1 infection marker), and NeuN (mature neuronal marker). Approximately 66% of infected cells became NeuN-positive neurons. The majority (~80%) of converted cells expressed the vascular glutamate transporter (vGLUT) of glutamatergic neurons. ND1 treatment reduced astrogliosis, and some iNeurons located/survived inside of the savaged ischemic core. Western blotting detected higher levels of BDNF, FGF, and PSD-95 in ND1-treated mice. MultiElectrode Array (MEA) recordings in brain slices revealed that the ND1-induced reprogramming restored interrupted cortical circuits and synaptic plasticity. Furthermore, ND1 treatment significantly improved locomotor, sensorimotor, and psychological functions. Thus, conversion of endogenous astrocytes to neurons represents a plausible, on-site regenerative therapy for stroke.

Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons in Vivo

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Characteristic changes in astrocyte properties during astrocyte-to-neuron conversion induced by NeuroD1/Ascl1/Dlx2

Reprogramming astroglia into neurons with hallmarks of fast-spiking parvalbumin-positive interneurons by phospho-site–deficient Ascl1

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Precise Integration of Direct Cell Reprogramming-Induced Neuronal Cells into Adult Neocortical Circuits

Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons

Decoding single-cell molecular mechanisms in astrocyte-to-iN reprogramming via Ngn2- and Pax6-mediated direct lineage switching

Reprogramming Astrocytes to Motor Neurons by Activation of Endogenous Ngn2 and Isl1

Efficient Dlx2-mediated astrocyte-to-neuron conversion and inhibition of neuroinflammation by NeuroD1

Conversion of Reactive Astrocytes to Induced Neurons Enhances Neuronal Repair and Functional Recovery After Ischemic Stroke

Transcriptional Mechanisms of Proneural Factors and REST in Regulating Neuronal Reprogramming of Astrocytes.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Myt1l induced direct reprogramming of pericytes into cholinergic neurons.

Reprogrammed Mouse Astrocytes Retain a “memory” of Tissue Origin and Possess More Tendencies for Neuronal Differentiation Than Reprogrammed Mouse Embryonic Fibroblasts

Efficient Generation of Dopaminergic Neurons from Mouse Ventral Midbrain Astrocytes

Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury.

Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex

ASCL1 induces neurogenesis in human Müller glia

Direct Reprogramming of Fibroblasts into Neural Stem Cells by Single Non-Neural Progenitor Transcription Factor Ptf1a